BioSenic
clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy
Best podcasts with BioSenic
Ranked by the Snipd community
Feb 2, 2024 • 32min
BioSenic developing severe knee osteoarthritis treatment
BioSenic, a clinical-stage company, discusses their late-clinical asset JTA-004 for severe knee osteoarthritis. They share data on its safety and efficacy at an international congress. Topics covered include the mechanism of action of JTA-004, attending events, potential administration frequency, other companies working on osteoarthritis, and future steps.
